Nautilus Biotechnology Inc
(NAUT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,315 | -33,626 | -19,122 | -8,409 | N/A |
| Depreciation Amortization | 3,025 | 2,163 | 1,452 | 742 | N/A |
| Accounts payable and accrued liabilities | 1,261 | 887 | 725 | 724 | N/A |
| Other Working Capital | -22 | -2,663 | -31 | 78 | N/A |
| Other Operating Activity | 6,810 | 4,517 | 2,431 | 612 | 0 |
| Operating Cash Flow | $-39,241 | $-28,722 | $-14,545 | $-6,253 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,269 | -1,283 | -1,013 | -482 | N/A |
| Purchase Of Investment | -221,795 | -183,745 | -100,035 | N/A | N/A |
| Sale Of Investment | 85,100 | 40,000 | 40,000 | 24,000 | N/A |
| Investing Cash Flow | $-138,964 | $-145,028 | $-61,048 | $23,518 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 335,409 | 335,409 | 335,409 | N/A | N/A |
| Common Stock Issued | 167 | 104 | 46 | N/A | N/A |
| Other Financing Activity | -8,129 | -8,129 | -8,082 | -2,069 | 0 |
| Financing Cash Flow | $327,447 | $327,384 | $327,373 | $-2,069 | $N/A |
| Beginning Cash Position | 37,219 | 37,219 | 37,219 | 37,219 | N/A |
| End Cash Position | 186,461 | 190,853 | 288,999 | 52,415 | N/A |
| Net Cash Flow | $149,242 | $153,634 | $251,780 | $15,196 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,241 | -28,722 | -14,545 | -6,253 | N/A |
| Capital Expenditure | -2,269 | -1,283 | -1,013 | -482 | N/A |
| Free Cash Flow | -41,510 | -30,005 | -15,558 | -6,735 | 0 |